Sari F, Bayram S, Pala G, Oskay D, Tufan A
Eur J Rheumatol. 2024; 11(1):20-26.
PMID: 39575952
PMC: 11365018.
DOI: 10.5152/eurjrheum.2024.24009.
Ghalwash D, El-Gawish A, Ammar A, Hamdy A, Ghanem R, Ghanem M
J Int Med Res. 2024; 52(10):3000605241289292.
PMID: 39387202
PMC: 11475091.
DOI: 10.1177/03000605241289292.
Herrera A, Leiva L, Espinoza I, Rios-Erazo M, Shakhtur N, Wurmann P
J Clin Med. 2024; 13(11).
PMID: 38892941
PMC: 11172875.
DOI: 10.3390/jcm13113228.
Mardale D, Opris-Belinski D, Bojinca V, Bojinca M, Pasaran E, Saulescu I
Clin Pract. 2023; 13(6):1561-1576.
PMID: 38131686
PMC: 10742904.
DOI: 10.3390/clinpract13060137.
Costa T, Rushton S, Watson S, Ng W
Rheumatol Immunol Res. 2023; 4(2):78-89.
PMID: 37818348
PMC: 10561071.
DOI: 10.2478/rir-2023-0012.
Sjögren's syndrome.
Balint G, Buchanan W, Kean C, Kean W, Rainsford K
Inflammopharmacology. 2023; 32(1):37-43.
PMID: 37195497
DOI: 10.1007/s10787-023-01222-z.
B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma.
Mohammadnezhad L, Shekarkar Azgomi M, La Manna M, Guggino G, Botta C, Dieli F
Int J Mol Sci. 2023; 24(9).
PMID: 37176092
PMC: 10179133.
DOI: 10.3390/ijms24098385.
A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance.
Hageman I, van Rooij I, de Blaauw I, Trajanovska M, King S
Orphanet J Rare Dis. 2023; 18(1):106.
PMID: 37147718
PMC: 10163740.
DOI: 10.1186/s13023-023-02719-0.
Development and testing of an alternative responder definition for EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
Wratten S, Abetz-Webb L, Arenson E, Griffiths P, Bowman S, Hueber W
RMD Open. 2023; 9(1).
PMID: 36931685
PMC: 10030922.
DOI: 10.1136/rmdopen-2022-002721.
Improving weight loss RCTs. Measuring the step weight change from a sustained change in frequency of a particular eating or exercise pattern.
Booth D, Laguna-Camacho A
Eur J Clin Nutr. 2022; 77(5):511-514.
PMID: 36474081
PMC: 10169651.
DOI: 10.1038/s41430-022-01247-7.
Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
Cooper C, Wratten S, Williams-Hall R, Bookman A, Ndife B, Hueber W
Rheumatol Ther. 2022; 9(6):1499-1515.
PMID: 36114443
PMC: 9561458.
DOI: 10.1007/s40744-022-00487-0.
Symptom-Based Cluster Analysis Categorizes Sjögren's Disease Subtypes: An International Cohort Study Highlighting Disease Severity and Treatment Discordance.
McCoy S, Woodham M, Bartels C, Saldanha I, Bunya V, Maerz N
Arthritis Rheumatol. 2022; 74(9):1569-1579.
PMID: 35594474
PMC: 9427679.
DOI: 10.1002/art.42238.
Genetic Variants of the Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome.
Flessa C, Zampeli E, Evangelopoulos M, Natsis V, Bodewes I, Huijser E
Front Immunol. 2022; 13:836824.
PMID: 35371038
PMC: 8964489.
DOI: 10.3389/fimmu.2022.836824.
A New Tool for Rapid Assessment of Acute Exercise-Induced Fatigue.
Lu Y, Yuan Z, Chen J, Wang Z, Liu Z, Wu Y
Front Hum Neurosci. 2022; 16:856432.
PMID: 35370582
PMC: 8965889.
DOI: 10.3389/fnhum.2022.856432.
Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life.
Tarn J, Lendrem D, McMeekin P, Lendrem C, Hargreaves B, Ng W
J Intern Med. 2022; 291(6):849-855.
PMID: 35018685
PMC: 9305875.
DOI: 10.1111/joim.13451.
The reliability and validity of the European League Against Rheumatism Sjögren Syndrome Patient Reported Index in patients with primary Sjögren syndrome: A Turkish version study.
Gur Kabul E, Keskin A, Demir P, Basakci Calik B, Cobankara V
Arch Rheumatol. 2021; 36(3):317-325.
PMID: 34870162
PMC: 8612494.
DOI: 10.46497/ArchRheumatol.2021.8012.
Development and Application of the Placebo Response Model in Clinical Trials for Primary Sjögren's Syndrome.
Wang Z, Zheng Q, Liu H, Li L
Front Immunol. 2021; 12:783246.
PMID: 34868062
PMC: 8635096.
DOI: 10.3389/fimmu.2021.783246.
Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.
Davies K, Ng W
Front Immunol. 2021; 12:702505.
PMID: 34381453
PMC: 8350514.
DOI: 10.3389/fimmu.2021.702505.
Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren's Syndrome.
Papa N, Minniti A, Maglione W, Pignataro F, Caporali R, Vitali C
Biomolecules. 2021; 11(7).
PMID: 34203480
PMC: 8301983.
DOI: 10.3390/biom11070953.
Management of Sjögren's Syndrome: Present Issues and Future Perspectives.
Vitali C, Minniti A, Pignataro F, Maglione W, Papa N
Front Med (Lausanne). 2021; 8:676885.
PMID: 34164418
PMC: 8215198.
DOI: 10.3389/fmed.2021.676885.